GHRP-2/Tesamorelin/MGF/Ipamorelin Blend Research & Listing Availability

Current GHRP-2/Tesamorelin/MGF/Ipamorelin Blend vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.

Current GHRP-2/Tesamorelin/MGF/Ipamorelin Blend vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.

About GHRP-2/Tesamorelin/MGF/Ipamorelin Blend

Pre-clinical / research-onlyAlso known as: GHRP-2 / Tesamorelin / MGF / Ipamorelin

A compounded four-peptide research blend combining two growth-hormone secretagogues (GHRP-2 and Ipamorelin), a GHRH analogue (Tesamorelin), and the IGF-1 splice peptide MGF, sold for growth-hormone-axis research. No human trial of this combination exists; it ships as a lyophilized powder, so the key checks are whether all four peptides are present and in the stated amounts.

What to check before you buy GHRP-2/Tesamorelin/MGF/Ipamorelin Blend:

  • A COA that confirms ALL FOUR components by mass spec — GHRP-2, Tesamorelin, MGF, and Ipamorelin individually — not a single combined "blend tested" line. The more components in a vial, the easier it is for one to be missing or substituted.
  • The stated amount of each peptide, with a COA dated within the last 6–12 months for that batch. Off-ratio blends are common when one component is cheaper to include.
  • Accurate total fill matching the label so each component lands where the math says. Under-filled blend vials skew every component's dose at once.

Each component has its own literature — Tesamorelin is separately FDA-approved, while the others are research-grade — but this specific four-peptide combination has not been tested in any registered human trial. Treat efficacy and dosing claims for the blend as unestablished.

Regulatory: Not FDA-approved as a blend (Tesamorelin is separately approved as Egrifta). No human trial of the combination exists; sold as research-grade material for non-clinical use.

Sources & references (4)

Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.

  1. [1]Bowers CY. Growth hormone-releasing peptide (GHRP). Cell Mol Life Sci 1998;54:1316–1329.
  2. [2]Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998;139:552–561.
  3. [3]Falutz J et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med 2007;357:2359–2370.
  4. [4]Goldspink G. Mechano-growth factor and its role in muscle hypertrophy and repair. Scand J Med Sci Sports 2005;15:138–146.

GHRP-2/Tesamorelin/MGF/Ipamorelin Blend Calculator Input Observations

There is insufficient calculator evidence here to describe a common GHRP-2/Tesamorelin/MGF/Ipamorelin Blend entered amount. Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length.

About GHRP-2/Tesamorelin/MGF/Ipamorelin Blend

A compounded four-peptide research blend combining two growth-hormone secretagogues (GHRP-2 and Ipamorelin), a GHRH analogue (Tesamorelin), and the IGF-1 splice peptide MGF, sold for growth-hormone-axis research. No human trial of this combination exists; it ships as a lyophilized powder, so the key checks are whether all four peptides are present and in the stated amounts.

GHRP-2/Tesamorelin/MGF/Ipamorelin Blend is a blend of GHRP-2, Ipamorelin, MGF, and Tesamorelin, so a COA has to confirm each component separately — a single purity figure for the mixture is not enough. Not FDA-approved as a blend (Tesamorelin is separately approved as Egrifta).

Frequently Asked Questions: GHRP-2/Tesamorelin/MGF/Ipamorelin Blend

Are current GHRP-2/Tesamorelin/MGF/Ipamorelin Blend offers available?

Current GHRP-2/Tesamorelin/MGF/Ipamorelin Blend vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.

What can I check if GHRP-2/Tesamorelin/MGF/Ipamorelin Blend listings become available?

Check the exact compound, format, labelled quantity, named laboratory, test date, and batch match. Confirm any future listing price, discount terms, and stock directly with the vendor. Catalog COA fields alone are not independent verification.

Does research activity establish current GHRP-2/Tesamorelin/MGF/Ipamorelin Blend availability?

No. Search interest, calculator entries, historical prices, related compounds, and other formats do not establish current offers in this comparison. Research information and navigation to other compounds remain available.